BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+15.39%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.55B
AUM Growth
+$3.55B
(+13%)
Cap. Flow
+$39.7M
Cap. Flow
% of AUM
1.12%
Top 10 Holdings %
Top 10 Hldgs %
73.18%
Holding
30
New
2
Increased
6
Reduced
5
Closed
–
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$41.3M |
| 2 |
Cidara Therapeutics
CDTX
|
$8.01M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$6.72M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$3.92M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$3.25M |
Top Sells
| 1 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$11.2M |
| 2 |
Puma Biotechnology
PBYI
|
$7.06M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$6.5M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$3.15M |
| 5 |
Neurocrine Biosciences
NBIX
|
$2.83M |
Sector Composition
| 1 | Healthcare | 86.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $432M | 12.18% | 3,609,298 +20,000 | +0.6% | +$2.4M |
|
2
Incyte
INCY
$16.5B
| $407M | 11.46% | 3,750,406 | – | – |
|
|
3
Ionis Pharmaceuticals
IONS
$6.79B
| $404M | 11.39% | 6,529,838 -105,000 | -2% | -$6.5M |
|
4
Gilead Sciences
GILD
$140B
| $281M | 7.91% | 2,774,596 | – | – |
|
|
RDUS
5
DELISTED
Radius Health, Inc.
RDUS
| $263M | 7.41% | 4,272,140 | – | – |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $197M | 5.56% | 1,034,428 | – | – |
|
|
7
Neurocrine Biosciences
NBIX
$13.8B
| $177M | 4.97% | 3,121,552 -50,000 | -2% | -$2.83M |
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $172M | 4.84% | 1,365,445 | – | – |
|
|
9
Agios Pharmaceuticals
AGIO
$2.19B
| $140M | 3.95% | 2,159,921 +50,000 | +2% | +$3.25M |
|
|
MDVN
10
DELISTED
MEDIVATION, INC.
MDVN
| $125M | 3.51% | 2,581,112 | – | – |
|
11
Halozyme
HALO
$8.56B
| $122M | 3.43% | 7,029,832 +100,000 | +1% | +$1.73M |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $111M | 3.13% | 205,000 | – | – |
|
13
Alnylam Pharmaceuticals
ALNY
$58.5B
| $107M | 3% | 1,132,499 | – | – |
|
14
Novavax
NVAX
$1.21B
| $69.9M | 1.97% | 8,330,000 | – | – |
|
|
TSRO
15
DELISTED
TESARO, Inc.
TSRO
| $64.3M | 1.81% | 1,229,582 +75,000 | +6% | +$3.92M |
|
|
CEMP
16
DELISTED
Cempra, Inc.
CEMP
| $62M | 1.75% | 1,991,900 +100,000 | +5% | +$3.11M |
|
|
JUNO
17
DELISTED
Juno Therapeutics, Inc.
JUNO
| $57.4M | 1.62% | 1,305,000 | – | – |
|
|
ALDR
18
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $49.9M | 1.41% | 1,510,150 | – | – |
|
|
KITE
19
DELISTED
Kite Pharma, Inc.
KITE
| $46.2M | 1.3% | 750,000 | – | – |
|
20
PTC Therapeutics
PTCT
$3.92B
| $42.2M | 1.19% | 1,302,912 | – | – |
|
|
SAGE
21
DELISTED
Sage Therapeutics
SAGE
| $41.3M | 1.16% | +708,663 | New | +$41.3M |
|
|
ICPT
22
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $38.2M | 1.08% | 255,719 +45,000 | +21% | +$6.72M |
|
|
23
Puma Biotechnology
PBYI
$254M
| $33.9M | 0.95% | 431,991 -90,000 | -17% | -$7.06M |
|
24
Prothena Corp
PRTA
$441M
| $21.8M | 0.61% | 320,000 | – | – |
|
|
INFI
25
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $21.2M | 0.6% | 2,700,737 | – | – |
|